6505-01-224-0176 Levonorgestrel and ethinyl estra
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 3
- Next due November 16, 2026
- Last price paid
- …
- Standard price
- $125.64 per PG
- DLA's catalog price, not a price paid
- Approved sources
- 1
- One approved manufacturer listed
- Awards on record
- 57
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Levonorgestrel and ethinyl estra
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 11-JAN-86
- Unit
- PG
- NSN
- 6505-01-224-0176
- NIIN
- 01-224-0176
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00555-9047-58 | DLA approved-source file |
| 0ET99 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | MYZLIRA 6 X 28 | FLIS part list | |
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | ENPRESSE 6 X 28 | FLIS part list |
| 4HH72 | A (Active) | 5 (Secondary reference) / 9 (Was the design control reference) | NDC51862-0510-06 | FLIS part list | |
| 6LMB8 | H (Obsolete entity has been discontinued) | 5 (Secondary reference) / 9 (Was the design control reference) | NDC52544-0291-28 | FLIS part list | |
| 6LMB8 | H (Obsolete entity has been discontinued) | 5 (Secondary reference) / 9 (Was the design control reference) | TRIVORA 6 X 28 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Product characteristics
| Code | Requirement | Description |
|---|---|---|
| AKJA | Active medicament medicinal strength | MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT 0.040 AND MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT 0.050 AND MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT 0.075 AND MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT 0.125 |
| MDES | Medical designation and grade | UNITED STATES PHARMACOPEIA |
| CXCY | Part name assigned by controlling agency | LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS (TRIVORA) 168S |
| CRLK | Primary container content quantity | TABLETS 28.000 |
| CQCT | Primary container type | DISPENSER, PLASTIC COMPACT |
| FEAT | Special features | 28 TABLETS PER EACH CYCLE COMPACT CONTAINING IN SEQUENCE: 6 TABLETS LEVONORGESTREL 0.050 MG AND ETHINYL ESTRADIOL 0.030 MG FOLLOWED BY 5 TABLETS LEVONORGESTREL 0.075 MG AND ETHINYL ESTRADIOL 0.040 MG FOLLOWED BY 10 TABLETS LEVONORGESTREL 0.125 MG AND ETHINYL ESTRADIOL 0.030 MG FOLLOWED BY 7 TABLETS OF INERT INGREDIENTS. STORE AT 20 - 25 C (68 - 77 F). (SEE USP CONTROLLED ROOM TEMPERATURE). |
| SUPP | Supplementary features | CONTAINS 6 CYCLES OF 28 TABLETS; MEDSEP ITEM FOR DOD,BERLEX LABS |
| CSCW | Total primary container quantity | 6 |
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3006600000 (Chemical contraceptive preps based on hormones etc)
- PINC
- 0036939
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| MC55 | Marine Corps (DM) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | PG | $56.67 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | PG | $56.67 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Marine Corps (DM) | 01-OCT-2025 | PG | $56.67 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | PG | $56.67 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | PG | $125.64 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
Packaging
FLIS packaging data of this item
FLIS packaging
- Level A
- Z (Special requirement)
- Level B
- Z (Special requirement)
- Unit container
- ZZ (Special requirement)
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 3 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0335DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 4 | PG | $125.64 per PG | … | … | No set-aside | No | November 12, 2026 | November 18, 20265 days left |
| SPE2DP27T0283DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 6 | PG | $125.64 per PG | … | … | No set-aside | No | November 11, 2026 | November 17, 20264 days left |
| SPE2DP27T0260DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 1 | PG | $125.64 per PG | … | … | No set-aside | No | November 8, 2026 | November 16, 20263 days left |
| SPE2DP27T0161DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 1 | PG | $125.64 per PG | … | … | No set-aside | No | October 25, 2026 | November 2, 2026Closed |
| SPE2DP27T0114DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 9 | PG | $125.64 per PG | … | … | No set-aside | No | October 14, 2026 | October 20, 2026Closed |
| SPE2DP26T5340DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 3 | PG | $125.64 per PG | … | … | No set-aside | November 11, 2026First seen | October 5, 2026Closed | |
| SPE2DP27T0021DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 1 | PG | $125.64 per PG | … | … | No set-aside | November 11, 2026First seen | October 7, 2026Closed | |
| SPE2DP26T3890DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 2 | PG | $125.64 per PG | … | … | No set-aside | November 3, 2026First seen | June 29, 2026Closed | |
| SPE2DP26T5246DIBBS only | 6505-01-224-0176 | Levonorgestrel and ethinyl estra | 2 | PG | $125.64 per PG | … | … | No set-aside | November 3, 2026First seen | September 30, 2026Closed |
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
57 award lines since 2013, 4 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 28 | September 15, 2023 |
| 3W8H0MR UNLIMITED, LLC | 10 | October 16, 2026 |
| 00E55Cardinal Health, Inc. | 10 | March 20, 2017 |
| 0AG09SZY HOLDINGS, LLC | 9 | September 28, 2026 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 9 | 2 |
| 2025 | 9 | 2 |
| 2024 | 1 | 1 |
| 2023 | 3 | 1 |
| 2022 | 22 | 1 |
| 2021 | 1 | 1 |
| 2017 | 1 | 1 |
| 2016 | 1 | 1 |
| 2015 | 2 | 2 |
| 2014 | 2 | 2 |
| 2013 | 6 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | DMS PHARMACEUTICAL GROUP INC | $9,724 | 28 |
| 2 | MR UNLIMITED, LLC | $3,391 | 8 |
| 3 | SZY HOLDINGS, LLC | $2,677 | 5 |
| 4 | CARDINAL HEALTH, INC. | $136 | 3 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26P1028From the item's award history | July 21, 2026 | SZY HOLDINGS, LLC | $2,100 |
| SPE2DP26V0742From the item's award history | May 22, 2026 | MR UNLIMITED, LLC | $399 |
| SPE2DP26V0743From the item's award history | May 22, 2026 | MR UNLIMITED, LLC | $399 |
| SPE2DP26V0054From the item's award history | October 14, 2025 | MR UNLIMITED, LLC | $745 |
| SPE2DP26V0067From the item's award history | October 14, 2025 | MR UNLIMITED, LLC | $71 |
| SPE2DP25V3656From the item's award history | September 10, 2025 | SZY HOLDINGS, LLC | $142 |
| SPE2DP25V2724From the item's award history | June 30, 2025 | MR UNLIMITED, LLC | $71 |
| SPE2DP25V2628From the item's award history | June 23, 2025 | SZY HOLDINGS, LLC | $150 |
| SPE2DP25V1988From the item's award history | May 6, 2025 | SZY HOLDINGS, LLC | $145 |
| SPE2DP25V1376From the item's award history | March 14, 2025 | SZY HOLDINGS, LLC | $140 |
| SPE2DP25V1137From the item's award history | February 26, 2025 | MR UNLIMITED, LLC | $1,427 |
| SPE2DP25V0891From the item's award history | February 4, 2025 | MR UNLIMITED, LLC | $45 |
| SPE2DP24V2520From the item's award history | September 4, 2024 | MR UNLIMITED, LLC | $234 |
| SPE2DP23F6218From the item's award history | September 15, 2023 | DMS PHARMACEUTICAL GROUP INC | $0 |
| SPE2DP23F6219From the item's award history | September 15, 2023 | DMS PHARMACEUTICAL GROUP INC | $0 |
| SPE2DP23F6220From the item's award history | September 15, 2023 | DMS PHARMACEUTICAL GROUP INC | $0 |
| SPE2DP22F6755From the item's award history | August 18, 2022 | DMS PHARMACEUTICAL GROUP INC | $0 |
| SPE2DP22F6573From the item's award history | August 8, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6574From the item's award history | August 8, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6576From the item's award history | August 8, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6565From the item's award history | August 7, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6566From the item's award history | August 7, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6567From the item's award history | August 7, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6568From the item's award history | August 7, 2022 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP22F6485From the item's award history | August 4, 2022 | DMS PHARMACEUTICAL GROUP INC | $0 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.